ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,541Medicare Part D Prescriptions Filled, Including Refills

Rank: 63 out of 337

$506K Total Retail Price of All Prescriptions

Rank: 75 out of 337

535 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 535 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 535 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 8,053 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
LISINOPRIL 428 343 1 2
SIMVASTATIN 373 310 2 1
OMEPRAZOLE 352 239 3 4
ATENOLOL 335 324 4 10
AMLODIPINE BESYLATE 334 256 5 3
FUROSEMIDE 302 241 6 8
LEVOTHYROXINE SODIUM 270 176 7 5
HYDROCHLOROTHIAZIDE 257 223 8 9
METFORMIN HCL 219 184 9 12
HYDROCODONE-ACETAMINOPHEN 217 100 S3 10 13
METOPROLOL TARTRATE 195 184 11 6
SYNTHROID 153 115 12 41
PANTOPRAZOLE SODIUM 150 110 13 36
SERTRALINE HCL 144 127 14 18
ATORVASTATIN CALCIUM 136 117 15 7
RANITIDINE HCL 135 111 16 30
PROAIR HFA 133 93 17 38
LOSARTAN POTASSIUM 129 101 18 15
METOPROLOL SUCCINATE 118 108 19 21
AZITHROMYCIN 113 73 20 51
TRAZODONE HCL 110 76 21 16
AMITRIPTYLINE HCL 109 56 R 22 75
CITALOPRAM HBR 108 99 23 17
WARFARIN SODIUM 103 92 24 11
FLUTICASONE PROPIONATE 101 59 25 34
GABAPENTIN 100 63 26 20
TRAMADOL HCL 99 70 27 32
ZOLPIDEM TARTRATE 98 67 28 23
GLIPIZIDE 93 70 29 45
TAMSULOSIN HCL 91 80 30 25
SPIRIVA 90 74 31 43
ALLOPURINOL 89 89 32 28
QUINAPRIL HCL 88 80 33 50
CARVEDILOL 87 81 34 73
FENOFIBRATE 82 63 35 48
LOVASTATIN 82 60 35 24
VERAPAMIL ER 80 76 37 77
POLYETHYLENE GLYCOL 3350 76 59 38 47
MELOXICAM 73 45 39 54
CLOPIDOGREL 72 58 40 42
ADVAIR DISKUS 69 43 41 44
MECLIZINE HCL 68 55 42 117
IBUPROFEN 68 23 42 64
PAROXETINE HCL 67 65 44 46
OXYCODONE HCL-ACETAMINOPHEN 64 58 S2 45 152
ACETAMINOPHEN-CODEINE 62 32 S3 46 142
ALPRAZOLAM 62 48 46 78
PRAVASTATIN SODIUM 62 60 46 14
DOXAZOSIN MESYLATE 59 59 49 68
LIPITOR 58 53 50 33
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 57 51 31
OXYCODONE HCL 56 39 S2 52 63
FLUOXETINE HCL 53 22 53 57
OXYCONTIN 52 23 S2 54 87
ENALAPRIL MALEATE 51 51 55 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.